Structure-function screening revealed antibiotic linezolid inhibited FASTKD2 interactions with mitochondrial RNA, thereby disrupting tumour network communication and augmenting efficacy of therapies targeting neuronal stimulation of tumour cells. Here, FASTKD2 is linked to neoplasm.